Supervised injection site up for debate Monday at health board meeting

Former drug user, health centres speak in favour of safer sites

Ray Harrison has seen people shoot up using water from toilets and puddles.

He’s pulled friends who were overdosing in the street to a phone booth to call 911, so they wouldn’t be tracked by police.

Now Harrison – a former drug user himself who says he’s been clean since the New Year’s Day 2014 – says it’s time for Ottawa to open a supervised injection site.

He believes they will help prevent people from spreading disease and give them a reason to access health care services, which could start them on a road to breaking their addictions.

“You need to be able to start somewhere and not necessarily when you hit rock bottom, when you get incarcerated,” Harrison told CBC News ahead of tonight’s Ottawa Board of Health meeting.

The city’s medical officer of health, Dr. Isra Levy, is expected to make his case at that meeting for why Ottawa should have supervised injection sites, and why Ottawa Public Health should support agencies that propose to set them up.

Community health centres will be at tonight’s Ottawa Board of Health meeting to offer Levy their full support, and Harrison is planning to be there, too.

“I think the safer injection site will save a lot of people, and the community, a lot of grief; along with the police [since] they’re not having to chase these people down in somebody’s backyard,” Harrison said.

‘The time is definitely now’

For many years Canadians heard only about the contentious Insite program in Vancouver.

That facility, which opened in 2003, has long been the only supervised injection site in the country – but as Levy notes in his report, a 2011 Supreme Court decision that granted Insite an exemption so its clients would not be charged for possessing illegal drugs has had a major impact across the country.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below